In addition,GATC Biotech said that the future application to enable direct sequencing of methylated bases will make the system attractive for regulatory studies for the pharmaceutical or diagnostics industry.
Pacific Biosciences, Europe, vice president Terry Pizzie said that Pacific Biosciences has chosen GATC Biotech to be their first European service provider because the company is experienced in applying major sequencing technologies in a broad spectrum of projects and in gearing up new sequencing technologies quickly for lab routines.
GATC Biotech chief technology officer Thomas Pohl said that they were looking forward to offering their customers PacBio’s sequencing platform and are confident that they will be able to offer the SMRT technology to their customers within a short period of time after successful installation.